Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Learn ways to generate income quickly with effective strategies. These tips will help you boost your earnings in no time.
21,313 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
When a Berkshire Hathaway leader makes a move with a high-profile name like Amazon, the market takes notice. This pie...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Exxon Mobil has widened its lead over the S&P 500 since being removed from the Dow in 2020, aided by a disciplined pl...
A decade of reinvested dividends can turn a modest $1,000 investment in Chevron into a much larger nest egg, even as ...
Oracle's latest guidance sparked a sell-off as investors weigh AI-driven capital outlays against cash flow. This arti...
New data shows meme coins have fallen sharply since their 2024 peak, wiping out billions and leaving the sector mired...
When a Opendoor director sells a sizable stake, investors wonder if it hints at trouble or simply liquidity needs. Th...
Two very different tech plays collide in 2026: Innodata edges into AI data preparation, while Workiva anchors large e...
Tom Cruise’s Digger teaser confuses viewers and even investors. This article breaks down what happened, why it matter...
Google bought YouTube for $1.65 billion in 2006. The founders walked away with hundreds of millions, and today YouTub...
Tesla is quietly scaling its energy storage and grid modernization business, a growth engine many investors overlook ...